Indeed, it has been reported that sEH inhibitors can reduce [11,42] or unchanged [50] the development of cardiac hypertrophy and diminish adverse cardiac remodeling in normotensive mice and rats subjected to pressure overload. This evidence concerns the gene EPHX2 and cardiac hypertrophy.